Probiotics for the prevention of necrotizing enterocolitis in neonates: An 8-year retrospective cohort study

Journal of Clinical Pharmacy and Therapeutics

Volumn 38, Issue 6, 2013, Pages 445-449

  Li, Dan ^a   Rosito, G ^b   Slagle, T ^b  

^a Sutter General Hospital   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

necrotizing enterocolitis; neonates; preterm; probiotics

Indexed keywords

ANTIBIOTIC AGENT; INDOMETACIN; PROBIOTIC AGENT; STEROID;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM INFANTIS; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FEMALE; GESTATIONAL AGE; HAZARD RATIO; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; NEC SCALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RATING SCALE; RETROSPECTIVE STUDY; STREPTOCOCCUS THERMOPHILUS; VERY LOW BIRTH WEIGHT;

NECROTIZING ENTEROCOLITIS; NEONATES; PRETERM; PROBIOTICS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIRTH WEIGHT; BREAST FEEDING; COHORT STUDIES; DUCTUS ARTERIOSUS, PATENT; ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT MORTALITY; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; PROBIOTICS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 84886951614     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12084     Document Type: Article

References (22)

1. Caplan M,. Chapter 73. Necrotizing enterocolitis and short bowel syndrome. In:, Gleason CA, Devaskar SU, eds. Avery's diseases of the newborn, 9th edn. Philadelphia, PA: Elsevier Saunders, 1022-1029, 2012.
2. Pietz JT,. To NEC or not to NEC: routine use of probiotics for premature infants. J Pediatr, 2011; 159: 520-521.
3. Neu J, Walker WA,. Necrotizing enterocolitis. N Engl J Med, 2011; 364: 255-264.
4. Embleton ND, Yates R,. Probiotics and other preventative strategies for necrotising enterocolitis. Semin Fetal Neonatal Med, 2008; 13: 35-43.
5. Sanders ME,. Probiotics: definition, sources, selection, and uses. Clin Infect Dis, 2008; 46: S58-S61.
6. AlFaleh K, Anabrees J, Bassler D, et al,. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev, 2011; 16: CD005496.
7. Bin-Nun A, Bromiker R, Wilschanski M, et al,. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr, 2005; 147: 192-196.
8. Braga TD, da Silva GA, de Lira PI, et al,. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr, 2011; 93: 81-86.
9. Costalos C, Skouteri V, Gounaris A, et al,. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev, 2003; 74: 89-96.
10. Dani C, Biadaioli R, Bertini G, et al,. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate, 2002; 82: 103-108.
11. Hoyos AB,. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis, 1999; 3: 197-202.
12. Kitajima H, Sumida Y, Tanaka R, et al,. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed, 1997; 76: F101-F107.
13. Lin HC, Su BH, Chen AC, et al,. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics, 2005; 115: 1-4.
14. Lin HC, Hsu CH, Chen HL, et al,. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics, 2008; 122: 693.
15. Manzoni P, Mostert M, Leonessa ML, et al,. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis, 2006; 42: 1735-1742.
16. Manzoni P, Rinaldi M, Cattani S, et al,. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA, 2009; 302: 1421-1428.
17. Mohan R, Koebnick C, Schildt J, et al,. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol, 2006; 44: 4025-4031.
18. Reuman PD, Duckworth DH, Smith KL, et al,. Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis, 1986; 5: 663-668.
19. Rougé C, Piloquet H, Butel MJ, et al,. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr, 2009; 89: 1828-1835.
20. Samanta M, Sarkar M, Ghosh P, et al,. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr, 2009; 55: 128-131.
21. Sari FN, Dizdar EA, Oguz S, et al,. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr, 2011; 65: 434-439.
22. Stratiki Z, Costalos C, Sevastiadou S, et al,. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev, 2007; 83: 575-579.